“…Rigorous clinical trials are much needed to evaluate AI algorithms to understand whether they translate to the clinical settings in which they will be used ( Daneshjou, 2022a ; Han et al., 2022 ). In addition to evaluating algorithms that aid in diagnostic support, researchers are trying to study whether AI is able to delineate body surface area and localize lesions of several skin diseases, including vitiligo, psoriasis, and atopic dermatitis ( Guo et al., 2022b ; Han et al., 2022 ; Hurault et al., 2022 ; Medela et al., 2022 ; Schaap et al., 2022 ).…”